EGFR c.214_215delinsGC ;(p.R72A)

Variant ID: 7-55210104-AG-GC

NM_005228.3(EGFR):c.214_215delinsGC;(p.R72A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.

Circulation Research
Rahman, H N Ashiqur HNA; Wu, Hao H; Dong, Yunzhou Y; Pasula, Satish S; Wen, Aiyun A; Sun, Ye Y; Brophy, Megan L ML; Tessneer, Kandice L KL; Cai, Xiaofeng X; McManus, John J; Chang, Baojun B; Kwak, Sukyoung S; Rahman, Negar S NS; Xu, Wenjia W; Fernandes, Conrad C; Mcdaniel, John Michael JM; Xia, Lijun L; Smith, Lois L; Srinivasan, R Sathish RS; Chen, Hong H
Publication Date: 2016-03-18

Variant appearance in text: EGFR: R72A
PubMed Link: 26879230
Variant Present in the following documents:
  • Main text
View BVdb publication page



Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.

Embo Reports
Haglund, Kaisa K; Schmidt, Mirko H H MHH; Wong, Esther Sook Miin ES; Guy, Graeme R GR; Dikic, Ivan I
Publication Date: 2005-07

Variant appearance in text: EGFR: R72A
PubMed Link: 15962011
Variant Present in the following documents:
  • Main text
View BVdb publication page